The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1215
August 15, 2005
View Complete Issue         Table of Contents 2019 
Duloxetine (Cymbalta) for Diabetic Neuropathic Pain
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Duloxetine (Cymbalta) for Diabetic Neuropathic Pain
August 15, 2005 (Issue: 1215)
Duloxetine hydrochloride (Cymbalta - Lilly), a selective serotonin and norepinephrine reuptake inhibitor (SNRI) available for treatment of depression, has also been approved by the FDA for treatment of neuropathic pain associated with diabetic...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Duloxetine (Cymbalta) for Diabetic Neuropathic Pain
Article code: 1215b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.